The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.
 
Saranya Chumsri
Consulting or Advisory Role - Eisai; Immunomedics; Novartis; Puma Biotechnology; Syndax
Research Funding - Array BioPharma; Merck
 
Jodi M Carter
No Relationships to Disclose
 
Yaohua Ma
No Relationships to Disclose
 
Douglas Hinerfeld
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Heather Ann Brauer
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Sarah Warren
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Consulting or Advisory Role - Petra Pharma
 
Torsten O Nielsen
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - NanoString Technologies; Veracyte
Patents, Royalties, Other Intellectual Property - PAM50 Breast Cancer Classifier
 
Karama Asleh
No Relationships to Disclose
 
Heikki Joensuu
Employment - Orion
Leadership - Sartar Therapeutics
Stock and Other Ownership Interests - Faron Pharmaceuticals; Orion
Consulting or Advisory Role - Neutron Therapeutics
Patents, Royalties, Other Intellectual Property - Sartar Therapeutics
 
Edith A. Perez
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
Consulting or Advisory Role - Daiichi Sankyo; Puma Biotechnology; Seagen
Research Funding - bioTheranostics (Inst); Genentech (Inst); Genomic Health (Inst); GlaxoSmithKline (Inst); LabCorp (Inst); Novartis (Inst)
 
Roberto Antonio Leon-Ferre
Travel, Accommodations, Expenses - Immunomedics
 
David W. Hillman
No Relationships to Disclose
 
Judy Caroline Boughey
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Minetta C. Liu
Research Funding - Eisai (Inst); GRAIL (Inst); Janssen Diagnostics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; ION Pharma (Inst); Menarini Silicon Biosystems; Merck; Pfizer
 
James N. Ingle
No Relationships to Disclose
 
Krishna R. Kalari
No Relationships to Disclose
 
Fergus Couch
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Ambry Genetics; Qiagen
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL; Qiagen
Other Relationship - Ambry Genetics
 
Keith L. Knutson
No Relationships to Disclose
 
Matthew P. Goetz
Consulting or Advisory Role - bioTheranostics; Context Therapeutics; Eisai; Genomic Health; Lilly; Novartis; Pfizer; Sermonix Pharmaceuticals
Research Funding - Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly
 
E Aubrey Thompson
No Relationships to Disclose